Market Clearance

Phase 4

We convert authorization into readiness. Clearance opens the door, but reimbursement, sales capability, and channel preparation are what determine whether anyone walks through it.

Phase Overview

Market Clearance begins when the FDA grants clearance or approval and the company is authorized to market its device commercially. The regulatory decision opens the door to commercial activity but does not guarantee commercial success. Reimbursement strategy, sales enablement, channel readiness, and market entry execution all need to be in place before clearance converts into revenue. This is the phase where everything prepared during review is finalized, activated, and put in the hands of the people who will sell and specify the device.

Reimbursement Strategy

Coding, coverage, and payment strategy finalized so the economic pathway is clear before the first order.

Sales Enablement

Sales tools, objection handling, and clinical evidence summaries completed and put into the field team's hands.

Channel Partner Readiness

Distributors and channel partners briefed, equipped, and aligned to a coordinated market entry.

Claims-Compliant Messaging

Messaging updated to what your clearance actually permits, so commercial teams sell confidently and within bounds.

Marketing Strategy

Go-to-market strategy finalized against the cleared indication, target accounts, and entry sequence.

Web Design & Development

The commercial website updated with cleared claims, product content, and conversion paths, and taken live.

Exhibition & Tradeshows

Conference and event presence planned and designed around the clinical calendar your launch depends on.

Copywriting

Product, clinical, and commercial copy finalized across every asset, translating technical value into persuasive messaging.

NEXT PHASE

Commercial Launch

With reimbursement resolved and the team prepared, your program moves into Commercial Launch, where the device enters the market and traction begins.

Continue